Novartis Gains Approval for First Malaria Treatment for Newborns and Babies
Swiss authorities approved the first malaria treatment specifically for newborns and infants under 11 pounds, Coartem Baby, developed by Medicines for Malaria Venture and Novartis, addressing a critical treatment gap for vulnerable populations.